Epidemiology |
Both are common conditions, affecting a large proportion of the older population. More common in females than males. |
Shared clinical features |
Frequent disconnect between symptoms and signs; spontaneous dysesthesias and evoked pain common to both entities, even in the absence of ongoing nerve damage. |
Shared co-morbidities |
Dry eye and other chronic neuropathic pain conditions often co-exist, including co-morbid conditions associated with pain amplification and psychological distress (e.g., pain, fatigue, sleep disorders, depression, anxiety, etc.). |
Abnormal somatosensory testing |
Hypoesthesia, hypo- or hyperalgesia, or allodynia commonly seen on somatosensory testing. Dynamic testing has revealed increased wind up, a surrogate metric of central sensitization in both conditions. |
Nerve injury implicated |
Anatomical abnormalities observed in corneal nerves consistent with nerve injury (confocal microscopy), similar to neuropathic pain elsewhere in the body (magnetic resonance imaging) |
Shared pathophysiology |
Somatosensory nerve sensitization, inflammation and supporting cell abnormalities are common to both entities. |
Heritability |
Both conditions appear to be heritable and shared genetic factors have been demonstrated in large twin studies. |
Overlapping therapeutic response |
Nerve modulators, such as calcium channel alpha 2 delta ligands (e.g., gabapentinoids), improve symptoms in some individuals. |